SCHEMBL16601016

SCHEMBL16601016

COC1(Cc2ccccc2)CCCC1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
CTSL P07711 4/20 0.42
CTSK P43235 4/20 0.42
CTSB P07858 3/20 0.42
GRIN2B Q13224 4/20 0.40
CYP46A1 Q9Y6A2 1/20 0.40
HSD17B3 P37058 1/20 0.39
OPRL1 P41146 2/20 0.39
OPRM1 P35372 2/20 0.39
OPRK1 P41145 1/20 0.39
CTSS P25774 1/20 0.37
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18727495 0.98 MAOA (0.44) MAOAMAOBCTSLCTSKCTSB
SCHEMBL11823681 0.83 MAOA (0.48) MAOAMAOBCTSLCTSKCTSB
SCHEMBL1574471 0.83 TACR1 (0.44) MAOAMAOBGRIN2BCYP46A1OPRM1
SCHEMBL13681482 0.82 ACHE (0.42) MAOAMAOBGRIN2BCYP46A1HSD17B3
SCHEMBL14000290 0.82 CYP46A1 (0.45) MAOAMAOBGRIN2BCYP46A1OPRL1
Hydrochloric Acid SCHEMBL3251338 0.82 TACR1 (0.43) MAOAMAOBGRIN2BCYP46A1OPRM1
SCHEMBL4825666 0.82 HSD17B3 (0.44) MAOAMAOBGRIN2BCYP46A1HSD17B3
SCHEMBL8767085 0.82 MAOA (0.47) MAOAMAOBCTSLCTSKCTSB
SCHEMBL1772885 0.79 MME (0.35) MAOBCTSLCTSBOPRM1CTSS
SCHEMBL4821650 0.79 MAOA (0.38) MAOAMAOBGRIN2BCYP46A1HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3036221-A1 SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B Luc Therapeutics, Inc. (US) 2016-06-29 EP disclosed
WO-2015048507-A1 SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B MNEMOSYNE PHARMACEUTICALS, INC. (US) 2015-04-02 WO disclosed